Second Embryonic Derivative Trial Moves Ahead

Second Embryonic Derivative Trial Moves Ahead, Maybe Dangerous | LifeNews.com: Reuters is reporting that Advanced Cell Technology has enrolled the first two patients for its experiments on human eyes using injected embryonic stem cells. The report says that one patient each has been signed up for its two experimental trials that were approved within the past seven months by the FDA; the patients were recruited at the Jules Stein Eye Institute, UCLA.